The PI3K/AKT/mammalian target of rapamycin (mTOR) signaling pathway is typically abnormally activated in many carcinomas (Michl and Downward, 2005; Johnson et al., 2010; Narayanankutty, 2019). The gene discussed is MTOR; the disease is carcinoma.